APC this week submitted a comment letter expressing concern over the California Board of Pharmacy's...
APC's joint comment letter with NCPA regarding HHS' interim peptide policy
Read APC's joint comment letter with the National Community Pharmacists Association regarding HHS' interim peptide policy, submitted on November 13 – supporting the policy and essentially seeking some clarifications and a temporary sourcing safeguard while manufacturers of the covered peptide APIs establish and demonstrate compliance with the policy’s testing and quality requirements.